Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

New molecular tags could allow MRI to track changes in the body
New molecular tags could allow MRI to track changes in the body
DURHAM, N.
Valeant drug price increase coincides with Calif. Aid-in-Dying legislation
Valeant drug price increase coincides with Calif. Aid-in-Dying legislation
When California’s aid-in-dying law takes effect this June, terminally ill patients who decide to end their lives could be faced with a hefty bill for the lethal medication.
Researchers point out gene responsible for sleep deprivation, metabolic disorders
Researchers point out gene responsible for sleep deprivation, metabolic disorders
The study is the first to identify that a conserved gene called translin works as a modulator of sleep in response to metabolic changes.
Bloomberg: Valeant's failing with Addyi, Sprout investors say. Why? 'Predatory pricing.'
Bloomberg: Valeant's failing with Addyi, Sprout investors say. Why? 'Predatory pricing.'
When Valeant Pharmaceuticals ($VRX) made its deal to buy the female libido pill maker Sprout, it agreed to pay $1 billion in cash and promised a share of future profits.
FDA Approves Bayer's KOVALTRY Antihemophilic Factor Recombinant for the Treatment of Children and Adults with Hemophilia A
FDA Approves Bayer's KOVALTRY Antihemophilic Factor Recombinant for the Treatment of Children and Adults with Hemophilia A
By a News Reporter-Staff News Editor at Clinical Trials Week The U.
Breckenridge Announces Approval for Gabapentin Oral Solution
Breckenridge Announces Approval for Gabapentin Oral Solution
By a News Reporter-Staff News Editor at Pharma Business Week Breckenridge Pharmaceutical, Inc.
FDA approves cinqair for severe asthma
FDA approves cinqair for severe asthma
Cinqair (reslizumab) has been approved by the U.
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
Gilead ordered to pay Merck $200 million in hepatitis C drug patent dispute
A federal jury on Thursday ordered Gilead Sciences Inc (GILD.
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
Regeneron and Bayer To Jointly Develop Novel Combination Therapy for Eye Diseases
TARRYTOWN, N.
NICE backs use of Johnson & Johnson's prostate cancer drug Zytiga
NICE backs use of Johnson & Johnson's prostate cancer drug Zytiga
The National Institute for Health and Care Excellence issued final draft guidance Monday recommending NHS reimbursement of Johnson & Johnson's Zytiga (abiraterone) for certain patients...
Profectus, Vyriad to develop oncolytic rVSV vaccines to treat cancer
Profectus, Vyriad to develop oncolytic rVSV vaccines to treat cancer
Profectus BioSciences and Vyriad have entered into a collaboration to develop oncolytic recombinant vesicular stomatitis virus (rVSV) vaccines for cancer immunotherapy.
Teva Launches Generic Campral In U.S.
Teva Launches Generic Campral In U.S.
Teva Pharmaceutical Industries Ltd.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand